<?xml version="1.0" encoding="UTF-8"?>
<p>Cell populations (CD45
 <sup>+</sup> cells) were analyzed with a BD LSR Fortessa (BD Biosciences) according to the following cell surface phenotypes: In the BM, (MDPs): Lin(*)
 <sup>-</sup>CD117
 <sup>+</sup>CD135
 <sup>+</sup>CD115
 <sup>+</sup>CD127
 <sup>-</sup>; (CDPs) Lin(*)
 <sup>-</sup>CD117
 <sup>low</sup>CD135
 <sup>+</sup>CD115
 <sup>+</sup>CD127
 <sup>-</sup>CD11c
 <sup>-</sup>; (cMoPs): Lin(**)
 <sup>-</sup>CD117
 <sup>+</sup>CD135
 <sup>-</sup>CD115
 <sup>+</sup>Ly6C
 <sup>+</sup>CD11b
 <sup>-</sup>. In the BM, spleen and blood (pre-DCs): Lin(*)
 <sup>-</sup>CD11c
 <sup>+</sup>MHCII
 <sup>-</sup>CD135
 <sup>+</sup>SirpÎ±
 <sup>-/low</sup> and Siglec-H
 <sup>-</sup>Ly6C
 <sup>-</sup> for cDC1-specific pre-DCs or Siglec-H
 <sup>-</sup>Ly6C
 <sup>+</sup> for cDC2-specific pre-DCs; In the BM and blood, (monocytes): Lin(**)
 <sup>-</sup> CD115
 <sup>+</sup>Ly6G
 <sup>-</sup>CD11b
 <sup>+</sup>Ly6C
 <sup>high</sup> or Ly6C
 <sup>low/neg</sup>. In the lungs, (DCs): Siglec-F
 <sup>-</sup>Ly6G
 <sup>-</sup>CD11c
 <sup>+</sup>MHCII
 <sup>+</sup> and CD64
 <sup>-</sup> for cDCs or CD64
 <sup>+</sup> for monocyte-derived DCs; (inflammatory monocytes): Siglec-F
 <sup>-</sup>Ly6G
 <sup>-</sup>Ly6C
 <sup>+</sup>CD11b
 <sup>+</sup>CCR2
 <sup>+</sup>CD11c
 <sup>-</sup>. Dead cells were excluded by propidium iodide staining. For analysis, 10
 <sup>6</sup> cells were acquired and the data were analyzed with FACSDiva or FlowJo software (TreeStar, US).
</p>
